Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4KS75 | — |
patient received this expire dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 64-year-old female patient who received HAB (Twinrix) (batch number 4KS75, expiry date 03-JAN-2025) for prophylaxis. On 06-JUN-2025, the patient received Twinrix. On 06-JUN-2025, an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: patient received this expire dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUN-2025 The pharmacist was called and reported the following he /she was just called to see if had any extended stability information on the Twinrix vaccine or not. The reporter asked about if the product was exposed to a temperature excursion on that pharmacist answered no, it was expired. They need to know how long after the expiration date was good. The reporter asked if any patient received this expire dose on that pharmacist said yes. During the call, reported that the vaccine was administered last Friday and set this as 06-Jun-2025, which led to expired vaccine used. The reporter was consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter.